Clinical Study
Low Serum Concentration of Obestatin as a Predictor of Mortality in Maintenance Hemodialysis Patients
Table 4
Clinical and biochemical characteristics in 94 prevalent hemodialysis patients, according to obestatin and TNFα 1.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The low obestatin or TNFα group was defined as obestatin < 7.12 ng/mL or TNFα < 17.75 pg/mL values below the median of distribution. Two-factor MANOVA. Significant () effects are given for obestatin (O), TNFα (T), and the interaction obestatin with TNF-α (O × T). Continuous variables that did not follow a normal distribution (dialysis vintage, interleukin-6, and leptin) were log transformed before their insertion in this model. Assessed by test. TNF-α: tumor necrosis factor-α; Ob: obestatin; DM: diabetes mellitus; CVD: cardiovascular disease in the past; DEI: daily energy intake; DPI: daily protein intake; nPNA: normalized protein nitrogen appearance; IL-6: interleukin-6; BMI: body mass index; ECW/TBW: extracellular water to total body water ratio; FMI: fat mass index; FFMI: fat-free mass index. |